Dexmethylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 63629-2175

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexmethylphenidate Hydrochloride (NDC 63629-2175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dmp_structure (Dh 01)

Chemical structure diagram of Dexmethylphenidate Hydrochloride, showing its molecular framework with key functional groups including the piperidine ring and phenyl group.*

FDA Label Image

Dh-02 (Dh 02)

Line graph comparing dexmethylphenidate concentration (ng/mL) over 24 hours for 20 mg extended-release capsules versus 2 x 10 mg tablets. Both forms show concentration peaks shortly after dosing and decline towards zero by 24 hours, illustrating their blood concentration profiles over time.*

FDA Label Image

Label (Lbl636292175)

Label for Dexmethylphenidate Hydrochloride Extended Release Capsules, 30 mg strength, manufactured by Par Pharmaceutical and relabeled by Bryant Ranch Prepack. The label includes the NDC 63629-2175-01, barcode, dosage form as capsules, a count of 100 capsules, and instructions for storage and safe keeping. The label displays the BRP Pharmaceuticals logo and indicates the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.